Test Price
1,600 AED✅ Home Collection Available
TBII (Thyrotropin‑Binding Inhibitory Immunoglobulin) Test in UAE | 1600 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓ 99.9% Diagnostic Sensitivity – ISO 15189 accredited competitive binding assay with rigorous lot‑to‑lot validation and internal quality controls.
- ✓ Premium Logistics – VIP mobile phlebotomy with temperature‑controlled cold‑chain transport for specimen integrity.
- ✓ Post‑Test Physician Teleconsultation – A structured clinical guidance call with a DHA‑licensed general practitioner is included at no extra cost.
- ✓ Insurance Direct Billing – Verify your plan via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TBII (Thyrotropin‑Binding Inhibitory Immunoglobulin) test is a highly specific competitive binding assay used to detect TSH receptor antibodies. This assay is essential for confirming Graves' disease, predicting relapse following antithyroid therapy, and differentiating autoimmune thyroid disorders from other causes of hyperthyroidism. The methodology employs a radioreceptor format with a monoclonal tracer, achieving a coefficient of variation below 5 % for intra‑ and inter‑assay precision.
| Parameters | Our TBII Test (ISO 15189 Accredited) | Standard Lab Alternative |
|---|---|---|
| Precision / Methodology | Competitive Binding Assay (Radioreceptor) with monoclonal tracer; CV <5 % | Bioassay for TSI; biological variability 15–20 % |
| Turnaround Time | 2–3 weeks (batched analysis with clear interpretive reporting) | 1–2 weeks (often non‑batched with variable cut‑offs) |
| Logistics & Sample Stability | VIP mobile phlebotomy; ISO‑standard cold‑chain transport; sample shipped refrigerated or frozen | Walk‑in draw; ambient transport risk may degrade labile antibodies |
| Pre‑test Consent | Electronic Form 35 delivered via WhatsApp; DHA‑compliant digital consent | Paper form; may omit mandatory consent documentation |
| Price | 1,600 AED (inclusive of home collection, teleconsultation, and insurance verification) | Varies; typically 1,400–1,750 AED without home services or medical guidance |
Physician Insight & Safety Protocols
Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132:
"Patients frequently ask whether a positive TBII result always means Graves' disease. In my clinical experience, when elevated TBII is interpreted alongside TSH, free T4, and orbital findings, it provides a confident diagnosis and helps tailor therapy—often avoiding unnecessary thyroid scanning. This test is a powerful guide, not a standalone verdict."
Medication Advisory Notice
⚠️ Important Medication Warning
Do not discontinue or alter any prescribed antithyroid medication (methimazole, carbimazole, propylthiouracil) or beta‑blockers without direct consultation with your treating physician. Abrupt dose changes can precipitate thyrotoxic crisis or relapse. Always consult your endocrinologist before making adjustments.
Safety Exclusion Criteria & Red Flags
Contraindications & Emergency Indicators
- This test is not intended for stand‑alone screening; it is indicated only when clinical suspicion of Graves' disease or autoimmune hyperthyroidism exists.
- Recent administration of radioisotopes (within 4 weeks) may interfere with the competitive binding assay and must be declared on the consent form.
- For patients under 18 years, an additional guardian consent is required in accordance with UAE Federal Law No. 2 of 2019.
- Seek emergency medical care if you experience: sudden rapid heartbeat exceeding 120 bpm at rest, confusion, severe tremor, high fever with diaphoresis, or loss of consciousness—these may indicate thyroid storm.
- Your medical data is processed under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL). Results are never shared without explicit written authorization.
Patient FAQ & Clinical Guidance
1. What exactly does a positive TBII test indicate?
A: A positive TBII result confirms the presence of TSH receptor antibodies, which are the causative immunoglobulins in Graves' disease. This finding strongly supports the diagnosis of autoimmune hyperthyroidism and can help predict the likelihood of relapse after medical therapy. However, it must always be interpreted alongside TSH, free T4, T3, and clinical orbital examination for a complete diagnostic picture.
2. How should I prepare for the TBII blood draw at home?
A: No fasting is required. You must complete the Send Out Consent Form (Form 35) provided electronically by our team via WhatsApp prior to collection. Our VIP phlebotomist will draw 2 mL of serum under strict temperature‑controlled cold‑chain protocols to preserve antibody stability during transport to the reference laboratory.
3. Why does the TBII report take 2–3 weeks?
A: The TBII assay is performed at a specialized send‑out reference laboratory using a validated competitive binding radioreceptor method. Samples are batched for processing once monthly to maintain high analytical precision and cost‑effectiveness; specimens received by the 7th of each calendar month are pooled together, analysed, and reported within 14–21 days.
4. Can I take this test if I am already on thyroid medication?
A: Yes. However, you must not stop or adjust your medication before the blood draw. A positive TBII result while on antithyroid drugs may indicate persistent autoimmune activity and help your physician decide whether to continue, taper, or switch therapy. Always inform the phlebotomist and your doctor about all current medications.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All TBII testing services provided by DNA Labs UAE are conducted in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data encryption, and result confidentiality are managed through secure digital platforms. Clinical safety and patient consent obligations follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. No personal health information is transmitted or shared without explicit, documented consent from the patient or legal guardian.
Clinical & Logistical Metadata
| Test Name | TBII (Thyrotropin‑Binding Inhibitory Immunoglobulin) Test |
| Price (AED) | 1,600 AED |
| Turnaround Time | 2–3 weeks (batched reference laboratory analysis) |
| Sample Type / Matrix | Serum (peripheral whole blood; 2 mL) |
| Methodology Used | Competitive Binding Assay (Radioreceptor) with monoclonal tracer |
| ICD-10-CM Code | E05.0 (Graves' disease with diffuse goiter), E05.9 (Thyrotoxicosis unspecified) |
| LOINC Code | 30511-3 (TSH receptor antibody [Presence] in Serum) |
| DHA Facility License & Address | License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians